Gino Santini Collegium Pharmaceutical, Inc (COLL) insider trading activity

COLL Quotes by TradingView

Gino Santini is Director of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 75,656 shares of COLL, which is worth approximately $2.2 Million. The most recent transaction as insider was on May 16, 2024, when has been sold 7,693 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.7K
0% 3M change
11.32% 12M change
Total Value Held $2.2 Million

GINO SANTINI Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
BUY
Grant, award, or other acquisition
-
7,693 Added 9.23%
75,656 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
-
9,792 Added 12.59%
67,963 Common Stock
May 19 2022
BUY
Grant, award, or other acquisition
-
14,035 Added 19.44%
58,171 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
-
9,941 Added 18.38%
44,136 Common Stock

Also insider at

HZNP
Horizon Therapeutics Public Ltd Co Healthcare
Director
AMAG
AMAG PHARMACEUTICALS, INC.
Director
ALNA
Allena Pharmaceuticals, Inc. Healthcare
Director
ICPT
INTERCEPT PHARMACEUTICALS, INC. Healthcare
Director
CMPS
COMPASS Pathways plc Healthcare
Director
GS

Gino Santini

Director
Dublin, L2

Track Institutional and Insider Activities on COLL

Follow COLLEGIUM PHARMACEUTICAL, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on COLL